|
![]() |
|
|
Serum_albumin: profile and news
Risk Assessment for and Strategies To Reduce Perioperative ... Apr 17, 2006 Immunomedics and IBC Pharmaceuticals Report on a Novel Protein ... Apr 25, 2006 Immunomedics and IBC Pharmaceuticals Report on a Novel Protein ... Apr 26, 2006 Paclitaxel efficacy enhanced by novel compound 73R Apr 20, 2006 Optimizing Catheter Positioning Improves Drug Distribution of ... Apr 26, 2006 RCT Hosting October 2006 Conference on the Future of Pichia ... Apr 24, 2006 Other information Indication For treatment of severe blood loss, hypervolemia, hypoproteinemia Pharmacology Regulates the colloidal osmotic pressure of blood. It is used to increase the circulating plasma volume, thereby reducing hemoconcentration and blood viscosity. Also used as a transport protein that binds naturally occurring, therapeutic and toxic materials in circulation. Mechanism Of Action Serum albumin acts as a high molecular weight, very soluble osmolyte Drug Category Serum substitutes; blood derivatives (16:00.00) Brand Names/Synonyms Serum albumin precursor; Optison Dosage Forms LIQUID Absorption Not Available Interactions Not Available Chemical IUPAC Name Human serum albumin Chemical Formula C2936H4624N786O889S41 Half Life Not Available Drug Type Approved Drug # Accession No BIOD00101 CAS Registry Number 9048-49-1 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |